Depletion of latent HIV-1 infection in vivo: a proof-of-concept study
Ginger Lehrman,Ian B. Hogue,Sarah Palmer,Cheryl Jennings,Celsa A. Spina,Ann Wiegand,Alan L. Landay,Robert W. Coombs,Douglas D. Richman,John W. Mellors,John M. Coffin,Ronald J. Bosch,David M. Margolis +12 more
Reads0
Chats0
TLDR
In this article, the ability of the histone deacetylase 1 (HDAC) inhibitor valproic acid to deplete persistent, latent infection in resting CD4+ T cells was evaluated.About:
This article is published in The Lancet.The article was published on 2005-08-13 and is currently open access. It has received 499 citations till now. The article focuses on the topics: Enfuvirtide.read more
Citations
More filters
Journal ArticleDOI
The many roles of histone deacetylases in development and physiology: Implications for disease and therapy
TL;DR: In this article, the expression of many HDAC isoforms in eukaryotic cells raises questions about their possible specificity or redundancy, and whether they control global or specific programs of gene expression.
Journal ArticleDOI
Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure
Ya Chi Ho,Liang Shan,Nina N. Hosmane,Jeffrey C. Wang,Sarah B. Laskey,Daniel I. S. Rosenbloom,Jun Lai,Joel N. Blankson,Janet D. Siliciano,Robert F. Siliciano,Robert F. Siliciano +10 more
TL;DR: The identification of replication-competent noninduced proviruses indicates that the size of the latent reservoir-and, hence, the barrier to cure-may be up to 60-fold greater than previously estimated.
Journal ArticleDOI
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
Nancie M. Archin,Abigail L. Liberty,Angela D. M. Kashuba,Shailesh K. Choudhary,Joann D. Kuruc,Amanda M. Crooks,Daniel C. Parker,Elizabeth M. Anderson,Mary F. Kearney,Matthew C. Strain,Douglas D. Richman,Michael G. Hudgens,Ronald J. Bosch,John M. Coffin,Joseph J. Eron,Daria J. Hazuda,David M. Margolis +16 more
TL;DR: It is demonstrated that a molecular mechanism known to enforce HIV latency can be therapeutically targeted in humans, provides proof-of-concept for histone deacetylase inhibitors as a therapeutic class, and defines a precise approach to test novel strategies to attack and eradicate latent HIV infection directly.
Journal ArticleDOI
Stimulation of HIV-1-Specific Cytolytic T Lymphocytes Facilitates Elimination of Latent Viral Reservoir after Virus Reactivation
Liang Shan,Kai Deng,Neeta S. Shroff,Christine M. Durand,S. Alireza Rabi,Hung-Chih Yang,Hao Zhang,Joseph B. Margolick,Joel N. Blankson,Robert F. Siliciano,Robert F. Siliciano +10 more
TL;DR: It is shown that after reversal of latency in an in vitro model, infected resting CD4(+) T cells survived despite viral cytopathic effects, even in the presence of autologous cytolytic T lymphocytes from most patients on HAART, demonstrating that stimulating HIV-1-specific CTLs prior to reactivating latent HIV- 1 may be essential for successful eradication efforts.
Journal ArticleDOI
HIV/AIDS epidemiology, pathogenesis, prevention, and treatment
TL;DR: This Seminar provides an update on epidemiology, pathogenesis, treatment, and prevention interventions pertinent to HIV-1.
References
More filters
Book
Generalized Linear Models
Peter McCullagh,John A. Nelder +1 more
TL;DR: In this paper, a generalization of the analysis of variance is given for these models using log- likelihoods, illustrated by examples relating to four distributions; the Normal, Binomial (probit analysis, etc.), Poisson (contingency tables), and gamma (variance components).
Journal ArticleDOI
Generalized linear models. 2nd ed.
Peter McCullagh,John A. Nelder +1 more
TL;DR: A class of statistical models that generalizes classical linear models-extending them to include many other models useful in statistical analysis, of particular interest for statisticians in medicine, biology, agriculture, social science, and engineering.
Journal ArticleDOI
Generalized Linear Models
TL;DR: Generalized linear models, 2nd edn By P McCullagh and J A Nelder as mentioned in this paper, 2nd edition, New York: Manning and Hall, 1989 xx + 512 pp £30
Journal ArticleDOI
Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy
Diana Finzi,Monika Hermankova,Theodore C. Pierson,Lucy M. Carruth,Christopher B. Buck,Richard E. Chaisson,Thomas C. Quinn,Karen Chadwick,Joseph B. Margolick,Ron Brookmeyer,Joel E. Gallant,Martin Markowitz,David D. Ho,Douglas D. Richman,Robert F. Siliciano +14 more
TL;DR: In a study of 22 patients successfully treated with HAART for up to 30 months, replication-competent virus was routinely recovered from resting CD4+ T lymphocytes, and generally did not show mutations associated with resistance to the relevant antiretroviral drugs.
Related Papers (5)
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
Nancie M. Archin,Abigail L. Liberty,Angela D. M. Kashuba,Shailesh K. Choudhary,Joann D. Kuruc,Amanda M. Crooks,Daniel C. Parker,Elizabeth M. Anderson,Mary F. Kearney,Matthew C. Strain,Douglas D. Richman,Michael G. Hudgens,Ronald J. Bosch,John M. Coffin,Joseph J. Eron,Daria J. Hazuda,David M. Margolis +16 more